Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
- Status
- RECRUITING
- Phase
- PHASE1
HER2-positive Metastatic Breast Cancer in Kazakhstan
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of HLD-0117 in Patients With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Generative AI Patient Education Module for Breast Oncology
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Pulsed Electric Field Ablation for Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Status
- RECRUITING
- Phase
- PHASE2
JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2